In vivo, EGCG can inhibit the expressions of TLR4, NF-κB, HMGB1, TNF-α, and IL-1β, and promote the expression of IL-10 in neuropathic pain rats [17]. The gene discussed is NFKB1; the disease is neuropathic pain.